Skip to content Skip to sidebar Skip to footer

Understanding Carbapenem-Resistant Pseudomonas Aeruginosa and Its Impact in Hospitals

An alarming global health issue is the proliferation of Carbapenem-Resistant Pseudomonas Aeruginosa (CRPA), a bacteria that poses a serious threat to public health, especially in hospital settings. In response to this issue, a retrospective case-control study was conducted at the Putuo Hospital, a teaching hospital in Shanghai, China. The study spanned the period from January…

Read more

Revolutionising Infection Prevention with Automated Detection Systems: A Look at NGD’s Offering

Poised to revolutionize the field of infection prevention through advanced automation, Next Gen Diagnostics (NGD) will expose industry professionals to its pioneering detection system at Becker's Healthcare Conference. Meticulously designed, NGD’s system remarkably combines robotic sample preparation, automated sequencing, bioinformatics, and efficient detection of bacterial infection transmission, making it possible for hospitals to detect and…

Read more

Oral Care Intervention Significantly Reduces Risk of Hospital-Acquired Pneumonia: Discovering Surprising Low-Cost Prevention Tactics

Australian researchers have discovered a surprising and cost-effective method to lower instances of non-ventilator hospital-acquired pneumonia (NV-HAP) within their facilities. According to a research team led by Professor Brett Mitchell, PhD, from Avondale University, implementing a strategy involving tooth brushing, toothpaste usage, and educational materials significantly cut back on disease incidences. Over a one-year period,…

Read more

Hospital Infection Therapeutics Market: Predicted Steady Growth and Key Insights on Detection and Prevention of HAIs

New York, NY – (Feb 10, 2026) - An upward trajectory is projected for the global market for Hospital Infection Therapeutics with estimates reaching a worth of USD 19.3 billion by 2033, up from USD 12.4 billion in 2023, undergoing a compound annual growth rate (CAGR) of 4.5% from 2024 to 2033. Hospital Infection Therapeutics…

Read more

Analysis of Oregon’s Struggle with Hospital-Acquired Infections: A Gap in Meeting National Standards

In 2024, Oregon hospitals were, disappointingly, underperforming on national standards for preventing infections related to medical procedures and surgeries, as reported by the Oregon Health Authority. A concerning trend emerged as Oregon's hospitals fared worse than their national counterparts, exhibiting higher rates of surgical site infections, catheter-associated urinary tract infections, central line-associated infections, and infections…

Read more

Analyzing the Rising Challenge of Hospital-Acquired Infections in Oregon

In 2024, Oregon's healthcare system faced a significant challenge. Nearly 1,000 patients acquired infections during their hospital stay, which resulted in safety standards being missed, according to a report by the Oregon Health Authority. Spanning 61 hospitals statewide, infections that developed post-surgery, through catheters, IV lines, or from drug-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA),…

Read more

Addressing High Rates of Hospital-Acquired Infections: The Importance of Often Overlooked Basic Measures

While new technologies frequently take center stage in medical innovation news, it is essential to remind ourselves of the critical role basic safety measures play in patient care. Infection prevention experts have expressed growing concerns, suggesting that the neglect of such simple but crucial safeguards contributes to the persistently elevated rates of hospital-acquired infections (HAIs)…

Read more

Innovative Approach to Infection Prevention: Expanding Surveillance on Vascular Access Devices

In healthcare settings, hospital-acquired infections continue to be a major area of concern, particularly those associated with vascular access devices. A noteworthy focus herein lies in bloodstream infections stemming from the use of such devices. With clinicians inserting hundreds of millions of peripheral intravenous catheters, known as PIVCs, annually; even if the risk for infection…

Read more

Emerging Challenges in Infection Control: Multidrug Resistance, Lassa Fever, and Tuberculosis

The field of healthcare is currently facing alarming challenges on multiple fronts, with recent studies providing insight into these pressing issues. One such concern is the escalating prevalence of multidrug-resistant (MDR) pathogens in hospital settings. A study conducted by researchers from Al-Quds University analyzed 10,007 unique bacterial samples from 13 government hospitals in the West…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]